Skip to main navigation
Skip to search
Skip to main content
UT MD Anderson Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at UT MD Anderson Cancer Center
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Heregulin-induced apoptosis
X. F. Le
, C. R. Varela
,
R. C. Bast
Experimental Therapeutics
Research output
:
Contribution to journal
›
Short survey
›
peer-review
23
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Heregulin-induced apoptosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Apoptosis Induction
100%
Heregulin
100%
Growth Inhibition
25%
Polypeptide
12%
Apoptosis
12%
Epithelial Cells
12%
Signaling Pathway
12%
Breast
12%
Signaling Molecules
12%
Mammalian Target of Rapamycin (mTOR)
12%
Nervous System
12%
Inhibitory Activity
12%
RNA Splicing
12%
Multiple Organs
12%
Anti-apoptotic Bcl-2
12%
Caspase-7
12%
G2 Arrest
12%
PKC Kinase
12%
Immunology and Microbiology
Programmed Cell Death
100%
Neu Differentiation Factor
100%
Phosphotransferase
25%
Kinase
25%
Caspase
12%
Neurological System
12%
RNA Splicing
12%
Bcl-2
12%
Growth Inhibition
12%
G2 Phase Cell Cycle Checkpoint
12%
Neuroscience
Programmed Cell Death
100%
Neu Differentiation Factor
100%
Kinase
12%
Epithelial Cells
12%
RNA Splicing
12%
Nervous System
12%
Polypeptide
12%
G2 Phase Cell Cycle Checkpoint
12%
Mammalian Target of Rapamycin
12%
Protein Bcl 2
12%
Caspase 7
12%
Biochemistry, Genetics and Molecular Biology
Programmed Cell Death
100%
Isoform
40%
Kinase
20%
Phosphotransferase
20%
RNA Splicing
20%
Growth Inhibition
20%
Bcl-2
20%
Mechanistic Target of Rapamycin
20%
G2 Phase Cell Cycle Checkpoint
20%
Caspase 7
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neu Differentiation Factor
100%
Phosphotransferase
12%
Polypeptide
12%
Antiapoptotic
12%
Mammalian Target of Rapamycin
12%
Protein Bcl 2
12%
Caspase 7
12%